Showing results (291-300 of 3,351) with videos related to

Sort By:
Pageof 336
The Lancet. Oncology|September 14, 2007
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trialDavid N Krag, Stewart J Anderson, Thomas B Julian, et al.
The Lancet. Oncology|August 14, 2020
Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trialLi Xuan, Yu Wang, Fen Huang, et al.
The Lancet. Oncology|March 11, 2015
Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014Sandra R Distelhorst, James F Cleary, Patricia A Ganz, et al.
The Lancet. Oncology|April 16, 2023
First-in-patient study of OTL78 for intraoperative fluorescence imaging of prostate-specific membrane antigen-positive prostate cancer: a single-arm, phase 2a, feasibility trialJudith A Stibbe, Hilda A de Barros, Daan G J Linders, et al.
The Lancet. Oncology|August 8, 2020
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 studyXu-Shan Sun, Yungan Tao, Christophe Le Tourneau, et al.
The Lancet. Oncology|August 8, 2020
Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysisZachary J Ward, Andrew M Scott, Hedvig Hricak, et al.
The Lancet. Oncology|April 13, 2023
Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization GroupMatthew J Ehrhardt, Jan M Leerink, Renée L Mulder, et al.
The Lancet. Oncology|April 1, 2021
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysisEmma Copland, Dexter Canoy, Milad Nazarzadeh, et al.
The Lancet. Oncology|April 8, 2015
Nail toxicities induced by systemic anticancer treatmentsCaroline Robert, Vincent Sibaud, Christina Mateus, et al.
The Lancet. Oncology|February 16, 2015
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based studyJenny J Ko, Wanling Xie, Nils Kroeger, et al.
Pageof 336